These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 12801318)

  • 1. Safety of nasal budesonide in the long-term treatment of children with perennial rhinitis.
    Möller C; Ahlström H; Henricson KA; Malmqvist LA; Akerlund A; Hildebrand H
    Clin Exp Allergy; 2003 Jun; 33(6):816-22. PubMed ID: 12801318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The updated role of budesonide in managing children and adolescents with allergic rhinitis.
    Ciprandi G
    Minerva Pediatr (Torino); 2024 Aug; 76(4):526-536. PubMed ID: 38407014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of nasal budesonide treatment on COPD patients with coexistent rhinitis.
    Calabrese C; Costigliola A; Maffei M; Simeon V; Perna F; Tremante E; Merola E; Leone CA; Bianco A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():2025-2032. PubMed ID: 29988687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Efficacy of Budesonide, Levocabastine, and Their Combination in Treatment of Vasomotor Rhinitis.
    Tan R; Meng Y; Wang Y; Zhang L; Wang C; Zhang L
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(6):321-328. PubMed ID: 37935139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring value in the treatment of symptoms of allergic rhinitis with nasal steroids.
    Curtiss FR
    J Manag Care Pharm; 2006 Mar; 12(2):168-9, 171-2. PubMed ID: 16515376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Once-daily budesonide aqueous nasal spray for allergic rhinitis: a review.
    Stanaland BE
    Clin Ther; 2004 Apr; 26(4):473-92. PubMed ID: 15189745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal steroid sprays in the treatment of rhinitis: is one better than another?
    Waddell AN; Patel SK; Toma AG; Maw AR
    J Laryngol Otol; 2003 Nov; 117(11):843-5. PubMed ID: 14670141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis.
    Day J; Carrillo T
    J Allergy Clin Immunol; 1998 Dec; 102(6 Pt 1):902-8. PubMed ID: 9847429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of intranasal budesonide in the treatment of perennial rhinitis in adults and children.
    Day JH; Andersson CB; Briscoe MP
    Ann Allergy; 1990 May; 64(5):445-50. PubMed ID: 2186673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal Corticosteroids: Topical Potency, Systemic Activity and Therapeutic Index.
    Daley-Yates PT; Larenas-Linnemann D; Bhargave C; Verma M
    J Asthma Allergy; 2021; 14():1093-1104. PubMed ID: 34526783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of Maxitrol in Pediatric Age Group Below Two Years With Adenoid Hypertrophy: A Retrospective Cohort Study.
    Halawani M; Alkhaldi A; Almajed A; Almutairi A; Alrashed M; Albakeet N; Alshiha W; Aldibasi O; Alshammari J
    Cureus; 2021 Apr; 13(4):e14736. PubMed ID: 34079682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards definitive management of allergic rhinitis: best use of new and established therapies.
    Hossenbaccus L; Linton S; Garvey S; Ellis AK
    Allergy Asthma Clin Immunol; 2020; 16():39. PubMed ID: 32508939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse Effects of Nonsystemic Steroids (Inhaled, Intranasal, and Cutaneous): a Review of the Literature and Suggested Monitoring Tool.
    Gupta R; Fonacier LS
    Curr Allergy Asthma Rep; 2016 Jun; 16(6):44. PubMed ID: 27207481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of bone metabolism side effects after 3 years of nasal topical steroids in children with allergic rhinitis.
    Emin O; Fatih M; Emre D; Nedim S
    J Bone Miner Metab; 2011 Sep; 29(5):582-7. PubMed ID: 21327885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal steroid perspective: knowledge and attitudes.
    Cingi C; Songu M
    Eur Arch Otorhinolaryngol; 2010 May; 267(5):725-30. PubMed ID: 19936773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised, crossover clinical trial, in healthy volunteers, to compare the systemic availability of two topical intranasal budesonide formulations.
    Algorta J; Pena MA; Francisco S; Abajo Z; Sanz E
    Trials; 2008 Jun; 9():34. PubMed ID: 18541030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal management of nasal congestion caused by allergic rhinitis in children: safety and efficacy of medical treatments.
    Scadding G
    Paediatr Drugs; 2008; 10(3):151-62. PubMed ID: 18454568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BSACI guidelines for the management of allergic and non-allergic rhinitis.
    Scadding GK; Durham SR; Mirakian R; Jones NS; Leech SC; Farooque S; Ryan D; Walker SM; Clark AT; Dixon TA; Jolles SR; Siddique N; Cullinan P; Howarth PH; Nasser SM;
    Clin Exp Allergy; 2008 Jan; 38(1):19-42. PubMed ID: 18081563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergic rhinoconjunctivitis in children.
    de Groot H; Brand PL; Fokkens WF; Berger MY
    BMJ; 2007 Nov; 335(7627):985-8. PubMed ID: 17991980
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.